World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01726036
Date of registration: 01/11/2012
Prospective Registration: No
Primary sponsor: TriHealth Inc.
Public title: Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial GMRT
Scientific title: Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial: The GMRT Study.
Date of first enrolment: October 2012
Target sample size: 274
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01726036
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
United States
Contacts
Name:     Mounira Habli, MD
Address: 
Telephone:
Email:
Affiliation:  TriHealth Inc.
Key inclusion & exclusion criteria

Inclusion Criteria:

- term infants delivered by cesarean section or vaginal delivery at Good Samaritan
Hospital during the time period of the study

- Infants with no blood drawn two hours prior to the circumcision

- Singletons

Exclusion Criteria:

- Infants with congenital anomalies and/or known chromosomal syndromes

- Preterm infants defined as less than 37 / 0 weeks gestation.

- Delivery secondary to non-reassuring fetal heart tracing, defined by the delivering
physician

- Infants of diabetic mothers.

- Infants of preeclamptic mothers on magnesium sulfate within 48 hours of delivery.

- Infants delivered by vacuum-assisted or forceps-assisted vaginal delivery.

- Infants of mothers who took steroids for fetal lung maturity within 7 days of
delivery. (This may apply to term infants if the mother had no prenatal care and her
gestational age was not known on arrival).

- Infants with a 5 minutes apgar score of less than 7

- Infants born to mothers with a history of drug abuse during pregnancy, currently on
methadone, or with Hepatitis C or HIV.



Age minimum: N/A
Age maximum: 4 Days
Gender: Male
Health Condition(s) or Problem(s) studied
Circumcision, Male
Intervention(s)
Device: Gomco Circumcision Clamp
Device: Mogen Circumcision Clamp
Primary Outcome(s)
Neonatal Salivary Cortisol Level [Time Frame: Approximately 2 hours before and 15 minutes after the procedure]
Post-procedure Neonatal Pain Score Using the CRIES Neonatal Pain Measurement Tool [Time Frame: CRIES assessment completed prior to the procedure and post procedure.]
Secondary Outcome(s)
Secondary ID(s)
H-11121
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 16/05/2019
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT01726036
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history